Amgen Inc (NASDAQ:AMGN)

Tuesday’s trading has closed, but AMGN is being traded in the after-hours session. After-Hours quote »
140.46
Data as of 4:14pm ET
 +0.39 / +0.28%
Today’s Change
105.76
Today|||52-Week Range
144.46
+23.12%
Year-to-Date
Amgen, Inc. Showing Strong Performance Despite Low Beta
1:37pm / Benzinga
Auxilium Pharmaceuticals Favors QLT Deal Over Endo Bid - Analyst Blog
Sep 23 / Zacks.com
AMGN, ACT And GILD, Pushing Drugs Industry Downward
Sep 29 / TheStreet.com
Zacks Rank #1 Additions for Tuesday - Tale of the Tape
Sep 23 / Zacks.com
Celldex (CLDX) Up on Pilot Study Initiation on CDX-301 - Analyst Blog
Sep 26 / Zacks.com
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog
Sep 22 / Zacks.com
'Fast Money' Recap: How to Trade After the Market's Drop
Sep 26 / TheStreet.com
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog
Sep 22 / Zacks.com
Seattle Genetics' Adcetris Positive in Durability Analysis - Analyst Blog
Sep 25 / Zacks.com
VIVUS and Auxilium Announce Stendra Label Expansion - Analyst Blog
Sep 19 / Zacks.com
BioMarin (BMRN) Faces Threat of Genericization for Kuvan - Analyst Blog
Sep 25 / Zacks.com
3 Biotechs Investors Should Watch
Sep 19 / MotleyFool.com
Acorda Skyrockets on $525M Civitas Therapeutics Deal - Analyst Blog
Sep 25 / Zacks.com
Stock Market News for September 19, 2014 - Market News
Sep 19 / Zacks.com
Gilead Scores with TAF-based HIV Regimen, Shares Up - Analyst Blog
Sep 25 / Zacks.com
Sanofi & MyoKardia Ink Deal to Develop Cardiomyopathies - Analyst Blog
Sep 18 / Zacks.com
Inovio/GeneOne Life Science Collaborate for Ebola Vaccine - Analyst Blog
Sep 25 / Zacks.com
Europe struggles to catch US biotech bulls
Sep 18 / FT.com
Zacks Rank #1 Additions for Thursday - Tale of the Tape
Sep 25 / Zacks.com
Merck Posts Positive Data on Osteoporosis Drug Odanacatib - Analyst Blog
Sep 17 / Zacks.com
'Fast Money' Recap: What Market? The Focus Remains on Apple
Sep 25 / TheStreet.com
UCB-Amgen Reveals Positive Data on Romosozumab for PMO - Analyst Blog
Sep 17 / Zacks.com
Celgene's Otezla Label Expanded to Include Plaque Psoriasis - Analyst Blog
Sep 24 / Zacks.com
Why Amgen Inc.'s Stock Is up 23% in 2014
Sep 17 / MotleyFool.com
Biotech Stock Roundup: Auxilium an Acquisition Target, Amgen Submits another BLA - A...
Sep 24 / Zacks.com
Synthetic Biologics' SYN-005 Gets Orphan Drug Designation - Analyst Blog
Sep 16 / Zacks.com
3 Top Dividend Growth Stocks to Buy in October
Sep 24 / MotleyFool.com
Is Illumina (ILMN) a Buy on Solid Q2, Strategic Road Map? - Analyst Blog
Sep 16 / Zacks.com
Amgen Files Blinatumomab Marketing Application in U.S. - Analyst Blog
Sep 23 / Zacks.com
Biotech stocks buoyed by bullish broker
Sep 02 / FT.com
Bayer/Regeneron Successfully Expand Eylea Label in Japan - Analyst Blog
Sep 23 / Zacks.com
 

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.